Science and health publishing giant Elsevier has acquired Windhover Information Inc., a leading biotech and pharma business intelligence provider. Windhover publishes several journals, such as In Vivo, Start-up and The Regulation Policy Market Access Report, which cover health care marketplace trends, business strategy, industry deal making, and medical start-ups.

Acquiring Windhover adds more than 100 journalists to Elsevier's staff and is expected to strengthen the company's health care industry coverage. "Adding Windhover's expert analysis of the pharmaceutical and medical device industries to our existing regulatory and general business news services and database expands both the depth and breadth of Elsevier's customer offerings," Elsevier Health Sciences CEO, Brian Nairn, said in a company statement.

This move comes after news last month that Elsevier was selling Reed Business Information, the company's primary business-to-business publisher, which also produces, among others, New Scientist and Variety magazines.